reSee.it Video Transcript AI Summary
The FDA and FTC prohibited manufacturers of nasal products from promoting or researching their effectiveness against COVID-19. Companies like Xlear and Cofix RX faced strong warnings for attempting to investigate their products. Various treatments, including hydroxychloroquine, ivermectin, and virosidal nasal sprays, were effective but met with government resistance. Higher doses of corticosteroids, zinc, vitamin D, vitamin C, quercetin, and famotidine showed promise, yet were largely ignored. Colchicine, proven to reduce hospitalization and death risk, received no acknowledgment from the federal government. Instead, the public was urged to fear the virus, adhere to lockdowns, and rely solely on vaccines, which were mandated every six months without exceptions. The focus was primarily on vaccination rather than effective treatments.